Sponsor Terms of Use
Effective September 30, 2025
The terms “Diligent,” “we,” “us” and “our” refer to Diligent Pharma, Inc. and its affiliates (“Diligent Pharma”). Use of the Diligent® Qualification Platform (the “Platform”) is subject to the following terms of use (“Terms of Use”). By clicking agree or using the Platform, you, as a Sponsor, affirmatively accept these Terms of Use. Please read these Terms of Use carefully and ensure that you understand them. If you do not agree to the Terms of Use, you may not use the Platform.
DILIGENT PHARMA MAY UPDATE THESE TERMS OF USE AT ANY TIME, IN ITS SOLE DISCRETION. EACH TIME YOU USE THE PLATFORM, THESE TERMS OF USE, AS THEY THEN READ, WILL GOVERN YOUR USE OF THE PLATFORM. IN THE EVENT OF AN UPDATE, YOUR CONTINUED USE OF THE PLATFORM FOLLOWING THE POSTING OF ANY CHANGES, SIGNALS YOUR UNDERSTANDING OF, AND AGREEMENT TO, SUCH CHANGES.
1. Certain Definitions
"Authorized Master User" refers to Sponsor’s employee or representative who is authorized by Sponsor to use the Platform and has been provided with user credentials. The Authorized Master User will have permissions and rights assigned within the Platform that allow the Authorized Master User to create additional Authorized Users for access to the Platform.
"Authorized Users" refers to Sponsor’s employees who have been authorized by Vendor to use the Platform and have been provided with user credentials.
"Sponsor" means you, as an entity seeking services from Vendors through the Platform.
“Vendor” means a clinical service provider who uses the Platform to respond to requests for information and qualifications.
2. Ability to Accept Terms of Use. The Platform is intended for use only by individuals who are at least 18 years old and by using the Platform you represent that you are at least 18 years old. If you are consenting to these Terms of Use on behalf of a legal entity, you represent and warrant that you have the authority to consent to these Terms of Use on behalf of the entity.
3. Scope and Platform License.
a) Platform Description. The Platform permits Sponsors seeking services from Vendors, to search for and request Vendor qualification credentials, including qualification questionnaires, also called Requests for Information (RFIs), and Vendor Qualification Assessment audit reports (or VQAs). The Platform utilizes various technologies, including artificial intelligence and machine learning tools to enhance search capabilities, automate processes, and provide intelligent matching between Sponsors and Vendors.
b) Vendor Services. All Vendors are independent contractors and are not employees, subcontractors or agents of Diligent Pharma. Diligent Pharma is not involved with, nor does it have any control over the actual performance of any services by Vendors, nor does it guarantee the timeliness, quality or business outcome of those services.
c) Platform License. Diligent Pharma hereby grants to Sponsors during the Term (defined below), a non-exclusive, non-transferable, limited right and license to use the Platform for internal business purposes (the "Platform License").
d) Sponsor Responsibilities. Sponsor is responsible for providing accurate and complete information. Sponsor should ensure compliance with all applicable laws and regulations in its business operations. Use of the Platform is at Sponsor’s discretion and at Sponsor’s own risk. It is Sponsor’s responsibility to ascertain and obey all applicable local, state, federal and international laws in regard to Sponsor’s use of the Platform and use of services from Vendors.
4. Artificial Intelligence
a) Integration. The Platform integrates artificial intelligence tools and services (“AI Tools”), to provide enhanced functionality including without limitation, automated vendor discovery, intelligent matching, response analysis, audit report generation, and chat-based search capabilities. By using the Platform, Sponsor consents to Diligent Pharma’s use of these AI Tools in processing Sponsor’s data and providing Platform services.
b) AI Data. Sponsor acknowledges and consents to Diligent Pharma using AI Tools to process and analyze Sponsor’s data, including Sponsor’s preferences, search queries, interaction patterns, and business information, to enhance Sponsor’s profile, improve Platform functionality and provide improved matching services. This processing is conducted in compliance with applicable data protection laws and regulations. The Platform may provide AI-generated recommendations, audit reports, vendor classifications, and other automated insights. Sponsors acknowledge that such content is generated through automated processes and should verify important information independently before making business decisions.
5. Data and Information
a) Sponsor Data. As a condition to the Platform License, Sponsor agrees to provide to Diligent Pharma, data and information related to Sponsor’s business and preferences (including Confidential Information), as requested by Diligent Pharma (collectively, the “Sponsor Data”). Sponsor Data may be processed through AI tools to enhance Platform functionality and to provide Platform services.
b) License to Sponsor Data. Sponsor hereby grants to Diligent Pharma a royalty-free, non-exclusive, worldwide right and license during the Term, to access, store and use the Sponsor Data as necessary to enforce its rights and perform its obligations under these Terms of Use. Sponsor represents and warrants that the Sponsor Data will be accurate and complete in all respects. Sponsor shall promptly correct any errors or inaccuracies related to the Sponsor Data which Sponsor becomes aware.
c) Analytical and Benchmarking Use. Notwithstanding anything to the contrary set forth in these Terms of Use, Sponsor agrees that Diligent Pharma is authorized to use Sponsor Data for Diligent Pharma's analytical and benchmarking purposes, and to improve its offerings and technology, provided that all such data is aggregated and de-identified to third parties. Any derivative works of, or improvements to Diligent Pharma's offerings, including the Platform, arising from the use of Sponsor Data in accordance with this Section are the exclusive property of Diligent Pharma.
d) Data Accuracy. Sponsor represents and warrants that all information provided to Diligent Pharma will be accurate and complete in all respects. Sponsor shall promptly correct any errors or inaccuracies related to such information of which it becomes aware.
6. Authorized Users
a) Individual Acceptance. Each Authorized User must accept these Terms of Use before accessing the Platform. This acceptance services as an acknowledgement of the Terms of Use and Platform usage requirements. All Authorized Users act on behalf of and under the authority of Sponsor, which shall remain fully responsible for all Authorized User actions and Platform usage.
b) Authorized Master User. The Authorized Master User assumes all responsibilities for managing the Sponsor’s user community on the Platform. These responsibilities include but are not limited to user account creation, user password assignment, user profile content maintenance, and managing Sponsor's requests for information from Vendors. All acts and omissions of the Authorized User community shall be deemed acts or omissions of Sponsor.
c) Unauthorized Activity. Sponsor is solely responsible for any use of the Platform that is enabled by means of Sponsor’s access information, even if it is unauthorized. If Sponsor suspects unauthorized activity or a security breach, they must notify Diligent Pharma immediately.
d) False Information. Sponsor may not provide false e-mail addresses or impersonate any person or entity, or otherwise provide misleading information in connection with their use of the Platform. Sponsor must designate an employee or agent to act as the contact person for receiving and managing all communications related to the Platform. The contact person may be changed upon written notice to Diligent Pharma.
7. Accuracy, Completeness and Timeliness of Information. Although Diligent Pharma makes reasonable efforts to ensure that all information included on the Platform is correct, accuracy cannot be guaranteed, and Diligent Pharma does not assume any responsibility or obligation for the accuracy, completeness, timeliness, or authenticity of information on the Platform, including AI Tool-generated content. Information obtained via the Platform should not be relied upon or used as the sole basis for making significant decisions without consulting primary or more accurate, complete or timely sources of information.
8. Use of the Diligent Platform
a) Permitted Use. Materials on the Platform or obtained through the Platform may be used only for internal business purposes related to Vendor qualification and not as part of any service offerings to third parties.
b) Prohibited Use. Improper use of information and improper use of any hardware or software with the intent to damage or interfere with the proper working of the Platform or to intercept any system, data or personal information from the Platform, is strictly prohibited. Sponsor may not interrupt or attempt to interrupt the operation of the Platform in any way and Diligent Pharma reserves the right, in its sole discretion, to terminate access to or use of the Platform at any time without notice. Termination of access or use of the Platform will not waive or affect any right or relief to which Diligent Pharma may be entitled at law or in equity.
c) Updates and Modifications. Diligent Pharma may from time to time develop patches or fixes or may find it necessary to install updates, upgrades and other modifications to the Platform, including updates to AI Tools and algorithms. These may from time to time be automatically installed without providing any additional notice or receiving any additional consent and Sponsor consents to this automatic update. If Sponsor fails to install any software updates or other required item, use of the Platform may be compromised.
9. Feedback. All remarks, suggestions, ideas, graphics, or other information communicated to Diligent Pharma through or in relation to the Platform (other than personally identifiable information or trademarked or Confidential Information) will forever be the property of Diligent Pharma. Diligent Pharma will be entitled to use such submissions for commercial or other purpose without compensation, credits or notice to the submitter or to any other person. Any use of information obtained from the Platform will be consistent with these Terms of Use and the Privacy Policy located on the Diligent Pharma website at https://www.diligentpharma.com/privacy/.
10. Ownership and Intellectual Property
a) Platform Ownership. Diligent Pharma owns all right, title and interest in and to the Platform and all programs, code, documentation, methods, information and other materials that are a part thereof, including all intellectual property rights therein. Diligent Pharma does not grant to Sponsor, and Sponsor does not obtain by virtue of these Terms of Use or otherwise, any proprietary right or interest in the Platform. Sponsor shall not reverse engineer or create any derivative works with respect to the Platform.
b) Sponsor Data. Subject to the licenses granted to Diligent Pharma in these Terms of Use, Sponsor retains all right, title, and interest in and to any Sponsor Data.
c) Platform Content. The content included on the Platform, such as text, design, graphics, logos, icons, images, audio clips, downloads, interfaces, code, software, any intellectual property, and the selection and arrangement of any of these, are the exclusive property of Diligent Pharma, its affiliates, its licensors and/or its content providers and is protected by copyright, registered trademark, and other applicable laws.
d) Intellectual Property. Intellectual property of Diligent Pharma, including trademarks, logos, and service marks as displayed on the Platform are registered and unregistered trademarks of Diligent Pharma, its affiliates, its licensors, its content providers, and other third parties. All such trademarks, logos, and service marks are the property of their respective owners. Nothing on the Platform shall be construed as granting by implication, estoppel, or otherwise, any license or right to use any trademark, logo, or service mark displayed on the Platform without Diligent Pharma’s prior written permission, except as otherwise described herein.
e) Restrictions. Any other use of information and/or material contained on the Platform, including, but not limited to, the modification, distribution, transmission, performance, broadcast, publication, licensing, reverse engineering, transfer or sale of, or the creation of derivative works from, any material, information, software, or services obtained from the Platform, is expressly prohibited.
f) Custom Work Product. “Custom Work Product” means all custom study-specific data, and any custom and/or new templates created via the Platform, made in the performance of Services specifically to meet the particular business needs of Sponsor under the applicable statement of work or other ordering document entered into between Diligent Pharma and Sponsor. The definition of “Custom Work Product” does not include the Platform. Sponsor shall own all right title and interest to any Custom Work Product to the extent specified in the applicable statement of work or other ordering document entered into between Diligent Pharma and Sponsor. Unless otherwise agreed to in writing by Sponsor, Diligent Pharma may not use or repurpose any Custom Work Product other than for the benefit of Sponsor.
g) Infringement Notices. Diligent Pharma respects the intellectual property rights of others and may remove content that it believes may infringe the intellectual property rights of others. If you believe that the Platform has infringed a party’s intellectual property rights, please notify Diligent Pharma at the following address: Diligent Pharma Inc., 179 Nassau Street, Suite 3A, Princeton, NJ 08542 USA.
11. Third-Party Products. Any software, services, goods or other products or technology that are provided by a third party, or that are provided by Diligent Pharma but are: (i) identified by Diligent Pharma with a brand name or logo that is not a Diligent Pharma brand name or logo, or (ii) provided subject to Sponsor's agreement to the third party's legal terms and conditions ("Third Party Products") are subject to the terms of the license and other agreement terms of the third party. Sponsor may be required to accept the end user license and other terms of the third party providers as a condition to use of the Third Party Products. All Third Party Products are provided "as is".
12. WARRANTIES; DISCLAIMERS
a) Each party represents and warrants to the other party that (a) such party has the required power and authority to enter into these Terms of Use and to perform its obligations hereunder; and (b) the execution of these Terms of Use and performance hereunder do not and will not violate any other agreement to which it is a party.
b) USE OF THE PLATFORM IS AT SPONSOR’S SOLE RISK. THE PLATFORM IS PROVIDED ON AN “AS IS” AND “AS AVAILABLE” BASIS. DILIGENT PHARMA RESERVES THE RIGHT TO RESTRICT OR TERMINATE ACCESS TO THE PLATFORM OR ANY FEATURE OR PART THEREOF AT ANY TIME. EXCEPT AS EXPRESSLY SET FORTH IN THESE TERMS OF USE, DILIGENT PHARMA EXPRESSLY DISCLAIMS ALL WARRANTIES OF ANY KIND, WHETHER EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO: IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE AND ANY WARRANTIES THAT MATERIALS ON THE PLATFORM ARE NON-INFRINGING, AS WELL AS WARRANTIES IMPLIED FROM A COURSE OF PERFORMANCE OR COURSE OF DEALING; THAT ACCESS TO THE PLATFORM WILL BE UNINTERRUPTED OR ERROR-FREE; THAT THE PLATFORM WILL BE SECURE; THAT THE PLATFORM WILL BE VIRUS-FREE; OR THAT INFORMATION ON THE PLATFORM WILL BE COMPLETE, ACCURATE, TIMELY, OR AUTHENTIC. THIS INCLUDES AI-GENERATED CONTENT, RECOMMENDATIONS, AND AUTOMATED PROCESSES.
c) SPONSOR IS SOLELY RESPONSIBLE FOR VERIFYING AI-GENERATED INFORMATION BEFORE MAKING BUSINESS DECISIONS. SPONSOR IS SOLELY RESPONSIBLE FOR ANY DAMAGE TO ITS COMPUTER SYSTEM OR LOSS OF DATA THAT RESULTS FROM THE DOWNLOAD OR UPLOAD OF ANY MATERIALS. NO ADVICE OR INFORMATION, WHETHER ORAL OR WRITTEN, OBTAINED FROM DILIGENT PHARMA OR THROUGH OR FROM THE PLATFORM SHALL CREATE ANY WARRANTY OF ANY KIND.
13. LIMITATION OF LIABILITY
a) SPONSOR HEREBY ACKNOWLEDGES THAT ANY INFORMATION SENT OR RECEIVED VIA THE PLATFORM MAY NOT BE SECURE AND MAY BE INTERCEPTED OR OBTAINED BY UNAUTHORIZED PARTIES. IT IS UNDERSTOOD AND ACKNOWLEDGED THAT FULL RESPONSIBILITY FOR USE OF THE PLATFORM IS AT SPONSOR’S SOLE RISK AND DISCRETION.
b) EXCEPT FOR DILIGENT PHARMA’S INDEMNIFICATION OBLIGATIONS IN THESE TERMS OF USE, DILIGENT PHARMA, ITS AFFILIATES OR BUSINESS PARTNERS WILL NOT BE LIABLE FOR ANY DIRECT, INDIRECT, PUNITIVE, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR OTHER DAMAGES ARISING OUT OF OR IN ANY WAY RELATED TO THE PLATFORM OR WITH THE DELAY OR INABILITY TO USE THE PLATFORM, OR FOR ANY INFORMATION OR SERVICES ADVERTISED IN OR OBTAINED THROUGH THE PLATFORM, OR OTHERWISE ARISING OUT OF THE USE OF THE PLATFORM, WHETHER BASED ON CONTRACT, TORT, STRICT LIABILITY OR OTHERWISE, EVEN IF DILIGENT PHARMA OR ANY OF ITS AFFILIATES OR BUSINESS PARTNERS HAS BEEN ADVISED OF THE POSSIBILITY OF DAMAGES.
c) IN NO EVENT SHALL THE AGGREGATE LIABILITY OF DILIGENT PHARMA AND ANY OF ITS REPRESENTATIVES FOR ANY CLAIM, LOSS OR DAMAGE ARISING OUT OF OR RELATED TO THESE TERMS OF USE EXCEED THE AMOUNTS PAID BY SPONSOR TO DILIGENT PHARMA IN THE TWELVE (12) MONTHS PRECEDING THE EVENT GIVING RISE TO THE APPLICABLE LIABILITY.
14. Indemnification.
a) Sponsor agrees to indemnify, defend and hold harmless Diligent Pharma and its officers, directors, employees, agents, licensors, and suppliers, from and against any and all losses, liabilities, expenses, damages and costs, including reasonable attorneys’ fees and court costs (“Losses”), in connection with any and all claims, actions or proceedings brought or asserted by a third party (“Claims”), arising or resulting from (i) Sponsor’s and its Authorized User’s use of the Platform, (ii) any services offered or accepted through the Platform and (iii) any violation of these Terms of Use. If technical disruption of the Platform or the systems supporting it occurs due to Sponsor’s or its Authorized Users’ action or inaction, the Sponsor agrees to be responsible for any and all Losses arising or resulting from that disruption. Diligent Pharma reserves the right, at its own expense, to assume exclusive defense and control of any matter otherwise subject to indemnification and, in such case, Sponsor agrees to cooperate with Diligent Pharma in defense of such matter.
b) Diligent Pharma agrees to defend, indemnify and hold harmless Sponsor and its officers, directors, employees, agents, licensors, and suppliers harmless from and against any and all Losses in connection with any and all Claims, arising out of or resulting from (i) the infringement of intellectual property rights of a third party by Diligent Pharma, (ii) material breach of Diligent Pharma’s obligations under these Terms of Use; and (iii) Diligent Pharma’s gross negligence or willful misconduct. Sponsor reserves the right, at its own expense, to assume exclusive defense and control of any matter otherwise subject to indemnification and, in such case, Diligent Pharma agrees to cooperate with Sponsor in defense of such matter.
15. Confidentiality.
a) Diligent Pharma will maintain reasonable administrative, physical, and technical safeguards for protection of the security, confidentiality and integrity of the Platform. Upon request, Diligent Pharma will provide a description of its security measures for the Platform (the "Security Documentation"). Sponsor acknowledges that the Security Documentation is sensitive confidential information of Diligent Pharma and agrees not to disclose the Security Documentation to any third party or use the Security Documentation for any purpose other than evaluating the security of the Platform. Sponsor agrees that Diligent Pharma is not responsible for any harm as a result of a security incident arising from use of the Platform unless the incident resulted from Diligent Pharma’s failure to properly implement and maintain the security measures described in its Security Documentation.
b) Each party recognizes that, in the course of their business relationship, they may obtain or have access to the Confidential Information (hereinafter defined) of the other party, (or Confidential Information of a Vendor, which such Party is obligated to maintain as confidential). The party from whom Confidential Information is provided or accessed is the “Disclosing Party,” and the party receiving or accessing the Confidential Information is the “Receiving Party.” The Receiving Party will not, except as necessary to perform its obligations under these Terms of Use, or as otherwise expressly permitted herein, disclose, communicate or divulge to another, or permit the disclosure, communication or divulgence to another, or use for the Receiving Party’s own benefit or the benefit of another, any Confidential Information of the Disclosing Party. The Receiving Party will (a) secure and protect such Confidential Information by using a level of care consistent with the maintenance of its own confidential and proprietary information of like kind, but in no event less than a commercially reasonable degree of care, (b) disclose such Confidential Information only to its employees, affiliate’s employees, agents and independent contractors with a need to know in connection with the purposes of this Agreement, and (c) advise each of its employees, affiliate’s employees, agents and independent contractors who have access to such Confidential Information of their duty of confidentiality with respect to same. The Receiving Party is liable for any violation of the terms of this Section resulting from the acts or omissions of its employees, affiliate’s employees, agents or independent contractors or Authorized Users. All Confidential Information is and shall remain the sole and exclusive property of its respective owner.
c) “Confidential Information” means all confidential, non-public, and proprietary information which would reasonably be understood to be confidential or proprietary in nature, whether the information was marked as such and whether disclosed in oral, written, machine-readable or other form. Confidential Information also includes (a) confidential information of Vendors made available via the Platform, and (b) personal information pertaining to employees, referral sources and independent contractors of a party, including any fee arrangements; and (c) information pertaining to past, present and prospective clients or Vendors including, without limitation, name, address, e-mail address, telephone numbers, telefax numbers, personal or business information, account numbers, service requirements, statements of account, financial information, and fees charged.
d) Except as necessary to perform the Receiving Party’s obligations or exercise its rights under these Terms of Use, the Receiving Party will not disclose, communicate or divulge to another party, or permit the disclosure, communication or divulgence to another, or use any Confidential Information. Receiving Party will (a) protect such Confidential Information by using at least the same degree of care it uses to protect its own confidential and proprietary information, but in no event less than a reasonable degree of care, (b) disclose such Confidential Information only to its employees, agents and independent contractors who each have a need to know in connection with these Terms of Use, and (c) advise each of its employees, agents and independent contractors who have access to such Confidential Information of the obligation to maintain the confidentiality of the information.
e) The obligations of non-use and disclosure set forth in this Section do not apply to information that is: (i) in the public domain or becomes generally known through no fault of the Receiving Party; (ii) rightfully known to Receiving Party without an obligation of confidence prior to disclosure hereunder; (iii) lawfully obtained without obligation of confidentiality from a third party entitled to disclose such information; (iv) required by law or regulation to be disclosed, but only to the extent and for the purposes of such required disclosure; or (v) disclosed in response to a valid order of a court or other governmental body, but only to the extent and for the purpose of such order.
f) If any disclosure is required under this Section, the Receiving Party shall promptly notify the Disclosing Party of the disclosure requirement and will cooperate with the Disclosing Party, at the Disclosing Party’s expense, to obtain a protective order or otherwise limit or avoid such compelled disclosure. Diligent Pharma’s use of Sponsor Data as permitted by these Terms of Use shall not constitute a breach of this Section.
16. Term and Termination. These Terms of Use shall remain in full force and effect while Sponsor uses the Platform (“Term”). Sponsor may terminate these Terms of Use upon thirty (30) days’ written notice to Diligent Pharma. Diligent Pharma may terminate Sponsor’s access to the Platform upon fifteen (15) days’ written notice to Sponsor.
17. General
a) Jurisdiction. These Terms of Use shall be interpreted and construed in accordance with the laws of the State of New Jersey, USA without regard to principles of conflicts of the law thereof, and any disputes arising hereunder shall be adjudicated in the federal or state courts of New Jersey, USA to whose jurisdiction the parties hereto hereby irrevocably submit and as to venue the parties hereto hereby waive all objections.
b) Entire Agreement. These Terms of Use constitute the entire agreement between Diligent Pharma and the Sponsor and supersede all prior agreements, negotiations, representations and proposals, written and oral, relating thereto.
c) No Assignment. Neither party may assign these Terms of Use or the rights and obligations hereunder without the express prior written consent of the other party, which consent shall not be unreasonably withheld. Notwithstanding the foregoing, either party may assign these Terms of Use without consent to: (i) an affiliate or subsidiary, or (ii) a successor in interest in connection with a merger, acquisition, or sale of all or substantially all of its assets. Subcontractors. Diligent Pharma may use affiliates, contractors, subcontractors and other third parties engaged in the ordinary course of its business to perform its obligations hereunder.
18. Contact Us
Questions or comments about these Terms of Use or the Platform may be directed to: admin@diligentpharma.com